Signal active
Organization
Contact Information
Overview
Curavit is a “virtual CRO”, purpose-built to design and execute decentralized clinical trials. The company works with our clients to design their trials from first principles, based on the team’s decades of experience in research and digital health technologies. For each trial, they assign an experienced principal investigator, who is an expert in the specific disease area, to develop the protocol and drive the regulatory submission process. Curavit manages participant recruitment, enrollment, and consent. Under the direction of the PI, their clinical study team executes the entire decentralized clinical trial.
About
Health Care, Pharmaceutical
2019
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Curavit Clinical Research headquartered in United States, North America, operates in the Health Care, Pharmaceutical sector. The company focuses on Health Care and has secured $40.0M in funding across 8 round(s). With a team of 11-50 employees, Curavit Clinical Research is actively contributing to advancements in Health Care. Their latest funding round, Series A - Curavit Clinical Research, raised $5.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
1
5
0
$5.0M
Details
1
Curavit Clinical Research has raised a total of $5.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Early Stage Venture | 5.0M |
Investors
Curavit Clinical Research is funded by 8 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Osage Venture Partners | - | FUNDING ROUND - Osage Venture Partners | 5.0M |
Clark Golestani | - | FUNDING ROUND - Clark Golestani | 5.0M |
Curavit Clinical Research | - | FUNDING ROUND - Curavit Clinical Research | 5.0M |
Matt Wallach | - | FUNDING ROUND - Matt Wallach | 5.0M |
Recent Activity
There is no recent news or activity for this profile.